AVDL
Avadel Pharmaceuticals
AVDL
AVDL
87 hedge funds and large institutions have $360M invested in Avadel Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 27 increasing their positions, 25 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
97% less call options, than puts
Call options by funds: $37K | Put options by funds: $1.08M
Holders
87
Holding in Top 10
3
Calls
$37K
Puts
$1.08M
Top Buyers
| 1 | +$16.9M | |
| 2 | +$4.03M | |
| 3 | +$3.12M | |
| 4 |
GTC
Ghost Tree Capital
New York
|
+$2.79M |
| 5 |
Morgan Stanley
New York
|
+$2.09M |
Top Sellers
| 1 | -$5.88M | |
| 2 | -$5.54M | |
| 3 | -$4.96M | |
| 4 |
EA
Emerald Acquisition
Seattle,
Washington
|
-$3.35M |
| 5 |
FPC
Falcon Point Capital
San Francisco,
California
|
-$2M |